查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1818424

藥物濫用即時檢測市場報告：2031 年趨勢、預測與競爭分析

Point-of-Care Testing (POCT) for Substance Abuse Market Report: Trends, Forecast and Competitive Analysis to 2031
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

全球藥物濫用即時檢測 (POCT) 市場預計將在醫院、診斷中心、康復中心、職場檢測機構以及家用檢測套組市場中迎來機會。預計2025年至2031年期間，全球藥物濫用即時檢測 (POCT) 市場的複合年成長率將達到9.0%。該市場的主要驅動力是對預防性醫療保健措施的日益重視，以及攜帶式和方便用戶使用型檢測設備的不斷發展。

  • 根據 Lucintel 的預測，依類型分類的膠體金市場預計在預測期內將出現高速成長。
  • 從應用來看，醫院預計將實現最高的成長。
  • 依地區分類，預計亞太地區將在預測期內實現最高成長。

藥物濫用即時檢測市場的新趨勢

由於技術創新和市場需求的變化，藥物濫用POCT市場正在快速發展。隨著全球打擊藥物濫用的力度加大，對更快、更準確、更具成本效益的檢測方法的需求日益成長。以下是塑造市場的五大關鍵趨勢：

  • 多重檢測設備：多重檢測設備能夠在單一樣本中檢測多種物質，在藥物濫用即時檢測 (POCT) 市場中日益普及。這些設備使醫療保健提供者、雇主和執法機構能夠同時檢測多種藥物，從而提高檢測效率。它們有助於減少單獨進行多項檢測的成本和時間，並提高結果的準確性。隨著多重檢測設備日益複雜，預計它們將成為各領域快速藥物檢測的首選解決方案。
  • 與數位健康平台整合：藥物濫用 POCT 設備正擴大與數位健康平台整合，從而實現即時數據收集、監控和彙報。這些平台允許醫療保健提供者和雇主遠端追蹤檢測結果，並監控個人的長期用藥情況。這種整合對於成癮康復計畫尤其有益，因為它有助於持續監控，並允許制定更個人化的治療方案。它還能改善患者與醫療保健提供者之間的溝通，從而提高藥物濫用管理計畫的整體有效性。
  • 家用檢測套組：家用檢測套組是藥物濫用即時檢測 (POCT) 市場的新興趨勢，特別適用於監測康復患者和治療依從性。這些套件為患者提供隱私、便利性和易用性，使他們能夠在舒適的家中進行藥物檢測。隨著藥物濫用監測成為長期治療方案的重要組成部分，家用檢測解決方案對於難以獲得醫療服務的患者而言是極具價值的工具。這些套件也為患者管理復原過程提供了更大的靈活性和自主性。
  • 非侵入性檢測：向唾液、汗液和呼吸分析等非侵入性檢測方法的轉變是藥物濫用POCT市場的關鍵趨勢。與傳統的尿液檢查和血液檢測相比，這些檢測具有許多優勢，包括更舒適、更少的隱私顧慮以及更快的檢測結果。非侵入性檢測在需要頻繁隨機檢測的職場、學校和執法部門尤其有用。隨著技術的進步，非侵入性檢測預計將變得更加可靠，並被廣泛接受作為常規藥物濫用監測的一部分。
  • 行動和可攜式檢測解決方案：行動和可攜式檢測解決方案正在改變即時檢測 (POCT) 市場，使藥物檢測更加便利靈活。這些可隨處存取的設備在醫療服務有限的偏遠地區和服務欠缺地區尤其有用。行動檢測設備還能即時快速地提供結果，為執法部門和職場的檢測提供便利。更小巧、更緊湊、更易於使用和攜帶的設備的發展正在擴大即時檢測 (POCT) 的覆蓋範圍，使藥物濫用監測隨時隨地進行。

多重檢測設備、數位健康整合、家用檢測套組、非侵入性檢測以及行動解決方案等新興趨勢正在改變藥物濫用即時診斷 (POCT) 市場。這些趨勢提高了檢測的可及性、效率和準確性，從而能夠更好地管理藥物濫用並監測康復情況。隨著這些趨勢的不斷發展，它們將塑造藥物檢測的未來，並改善全球個人和社區的治療效果。

藥物濫用 POCT 市場的最新趨勢

藥物濫用 POCT 市場的最新趨勢受到技術進步、藥物濫用加劇以及對更高效檢測解決方案的需求的推動。這些發展正在改變醫療保健、職場和執法部門的藥物檢測模式。以下是重塑市場的五個近期關鍵趨勢。

  • 快速多重藥物檢測簡介：快速多重藥物檢測是即時檢驗 (POCT) 市場的重大發展。這些檢測可以在單一樣本中檢測多種物質，從而為醫療保健提供者、雇主和執法部門提供更快、更有效率的結果。多重藥物檢測省去了對每種物質進行單獨檢測所需的時間和成本，有助於簡化各種環境下的藥物檢測流程。這項發展對於專注於監測多種藥物使用問題患者的專案以及改善職場安全至關重要。
  • 即時監控的數位整合技術進步：數位技術的最新進展使得即時檢測 (POCT) 設備與數位平台的整合更加便捷，從而實現即時監控和報告。醫療保健提供者和雇主現在可以即時追蹤藥物檢測結果，確保更快地介入並更好地管理藥物濫用案例。這項進展對於成癮治療計畫尤其有益，因為持續監控藥物使用至關重要。此外，它還能確保更準確、更及時的決策，進而增強職場藥物檢測項目的效果。
  • 非侵入性檢測技術的發展：唾液、汗液和呼吸分析等非侵入性檢測方法在即時檢測（POC​​T）市場中取得了長足進步。這些方法創傷小、操作便捷，非常適合在學校、職場和醫療保健場所使用。執法機構也正在進一步擴展非侵入性檢測技術，用於街頭毒品檢測。隨著這些技術的進步，它們預計將變得更加可靠，並獲得更廣泛的認可，尤其是在需要頻繁或隨機檢測的環境中。
  • 提升檢測設備的準確性和靈敏度：藥物濫用即時檢測 (POCT) 設備的最新進展致力於提高檢測的準確性和靈敏度。這包括開發更精確的方法來檢測體內微量物質，例如Fentanyl，芬太尼是鴉片類藥物氾濫的重要關注點。透過提高檢測可靠性，這些創新有助於減少假陽性和假陰性，確保檢測結果準確可靠。提高準確性對於成癮治療、職場藥物檢測和執法監控至關重要。
  • 監管部門支持加快檢測設備核准：監管機構擴大支持加快藥物濫用即時檢測設備的核准，從而加快新型和改進型檢測解決方案的上市速度。例如，能夠同時檢測多種藥物的設備正在獲得更快的監管核准，確保醫療保健提供者、雇主和執法機構擁有應對日益嚴重的藥物濫用問題所需的工具。這些監管變化正在推動即時檢測 (POCT) 市場的創新。

藥物濫用即時檢測 (POCT) 市場的最新趨勢，包括多重藥物檢測、數位化整合、非侵入性檢測、更高的準確性以及監管支持，正在徹底改變藥物檢測格局。這些進步提高了檢測的速度、準確性和可近性，對於在醫療保健、職場和執法環境中更好地管理藥物濫用至關重要。隨著這些技術的不斷發展，它們將在打擊藥物濫用方面發揮關鍵作用。

目錄

第1章摘要整理

第2章 市場概況

  • 背景和分類
  • 供應鏈

第3章：市場趨勢及預測分析

  • 宏觀經濟趨勢與預測
  • 產業驅動力與課題
  • PESTLE分析
  • 專利分析
  • 法規環境

4. 全球藥物濫用即時檢測市場（依類型）

  • 概述
  • 依類型進行吸引力分析
  • 膠體金基底：趨勢與預測（2019-2031）
  • 基於螢光層析法的趨勢與預測（2019-2031）

5. 全球藥物濫用即時檢測市場（依應用）

  • 概述
  • 依用途進行吸引力分析
  • 醫院：趨勢與預測（2019-2031）
  • 診斷中心：趨勢與預測（2019-2031）
  • 復健中心：趨勢與預測（2019-2031）
  • 職場測試實驗室：趨勢與預測（2019-2031）
  • 家庭檢測套組：趨勢與預測（2019-2031）

第6章 區域分析

  • 概述
  • 依地區分類：全球藥物濫用即時檢測市場

7. 北美藥物濫用即時檢測市場

  • 概述
  • 北美藥物濫用即時檢測市場（依類型）
  • 北美藥物濫用即時檢測市場（依應用）
  • 美國藥物濫用即時檢測市場
  • 墨西哥藥物濫用即時檢測市場
  • 加拿大藥物濫用即時檢測市場

8. 歐洲藥物濫用即時檢測市場

  • 概述
  • 歐洲藥物濫用即時檢測市場（依類型）
  • 歐洲藥物濫用即時檢測市場（依應用）
  • 德國藥物濫用即時檢測市場
  • 法國藥物濫用即時檢測市場
  • 西班牙藥物濫用即時檢測市場
  • 義大利藥物濫用即時檢測市場
  • 英國藥物濫用即時檢測市場

9. 亞太地區藥物濫用即時檢測市場

  • 概述
  • 亞太地區藥物濫用即時檢測市場（依類型）
  • 亞太地區藥物濫用即時檢測市場（依應用）
  • 日本藥物濫用POCT市場
  • 印度藥物濫用即時檢測市場
  • 中國藥物濫用即時檢測市場
  • 韓國藥物濫用POCT市場
  • 印尼藥物濫用即時檢測市場

10. 其他地區藥物濫用 POCT 市場

  • 概述
  • 世界其他地區藥物濫用即時檢測市場（依類型）
  • 世界其他地區藥物濫用即時檢測市場（依應用）
  • 中東地區藥物濫用即時檢測市場
  • 南美洲區域藥物濫用即時檢測市場
  • 非洲區域藥物濫用即時檢測市場

第11章 競爭分析

  • 產品系列分析
  • 營運整合
  • 波特五力分析
    • 競爭對手之間的競爭
    • 買方的議價能力
    • 供應商的議價能力
    • 替代品的威脅
    • 新進入者的威脅
  • 市佔率分析

第12章：機會與策略分析

  • 價值鏈分析
  • 成長機會分析
    • 依類型分類的成長機會
    • 依應用分類的成長機會
  • 全球藥物濫用即時檢測市場的新趨勢
  • 戰略分析
    • 新產品開發
    • 認證和許可
    • 合併、收購、協議、合作和合資企業

第13章 價值鏈主要企業的公司簡介

  • 競爭分析
  • Roche
  • Danaher
  • Abbott
  • Siemens
  • Beijing Hotgen BIoTech
  • Hangzhou BIoTest BIoTech Co.
  • Assure Tech
  • Orient Gene
  • Thermo Fisher

第14章 附錄

  • 圖表目錄
  • 表格一覽
  • 調查方法
  • 免責聲明
  • 版權
  • 簡稱和技術單位
  • 關於我們
  • 聯絡處

The future of the global point-of-care testing (POCT) for substance abuse market looks promising with opportunities in the hospital, diagnostic center, rehabilitation centers, workplace testing facilities, and home testing kits markets. The global point-of-care testing (POCT) for substance abuse market is expected to grow with a CAGR of 9.0% from 2025 to 2031. The major drivers for this market are the rising focus on preventive healthcare measures and the increasing development of portable and user-friendly testing devices.

  • Lucintel forecasts that, within the type category, based on colloidal gold is expected to witness higher growth over the forecast period.
  • Within the application category, the hospital is expected to witness the highest growth.
  • In terms of region, APAC is expected to witness the highest growth over the forecast period.

Emerging Trends in the Point-of-Care Testing (POCT) for Substance Abuse Market

The Point-of-Care Testing (POCT) for substance abuse market is evolving rapidly, driven by technological innovations and changing market needs. The demand for faster, more accurate, and cost-effective testing methods is growing as the global fight against substance abuse intensifies. Here are five key trends reshaping the market.

  • Multiplex Testing Devices: Multiplex testing devices that can detect multiple substances in a single sample are gaining popularity in the POCT market for substance abuse. These devices allow healthcare providers, employers, and law enforcement to test for a range of drugs simultaneously, making testing more efficient. They help reduce the cost and time associated with performing multiple separate tests and improve the accuracy of results. As multiplex devices become more sophisticated, they are expected to become the preferred solution for rapid drug testing across various sectors.
  • Integration with Digital Health Platforms: POCT devices for substance abuse are increasingly being integrated with digital health platforms, enabling real-time data collection, monitoring, and reporting. These platforms allow healthcare providers and employers to track test results remotely and monitor individuals' substance use over time. This integration is particularly beneficial for addiction recovery programs, as it facilitates continuous monitoring and allows for more personalized treatment plans. It also improves communication between patients and healthcare providers, enhancing the overall effectiveness of drug abuse management programs.
  • At-Home Testing Kits: At-home testing kits are becoming a growing trend in the POCT market for substance abuse, particularly for individuals undergoing rehabilitation or monitoring treatment adherence. These kits provide privacy, convenience, and ease of use for patients, allowing them to test for drugs in the comfort of their homes. As substance abuse monitoring becomes a more integral part of long-term treatment programs, at-home testing solutions offer a valuable tool for individuals who may not have easy access to medical facilities. These kits also offer more flexibility and autonomy for patients managing their recovery process.
  • Non-Invasive Testing Methods: The shift towards non-invasive testing methods such as saliva, sweat, and breath analysis is an important trend in the POCT market for substance abuse. These methods offer several advantages over traditional urine and blood testing, including increased comfort, reduced privacy concerns, and faster results. Non-invasive testing is particularly useful in workplaces, schools, and law enforcement settings where frequent, random testing is needed. As the technology improves, non-invasive methods are expected to become more reliable and widely accepted as part of routine substance abuse monitoring.
  • Mobile and Portable Testing Solutions: Mobile and portable testing solutions are transforming the POCT market by making drug testing more accessible and flexible. With the ability to test anywhere, these devices are particularly useful in remote or underserved areas where access to healthcare facilities is limited. Mobile testing units are also beneficial for law enforcement and workplace testing, providing rapid results in real-time. The development of smaller, more compact devices that are easy to use and carry is expanding the reach of POCT, ensuring that substance abuse monitoring can take place anytime and anywhere.

Emerging trends such as multiplex testing devices, digital health integration, at-home testing kits, non-invasive testing methods, and mobile solutions are transforming the POCT market for substance abuse. These trends enhance the accessibility, efficiency, and accuracy of testing, enabling better substance abuse management and recovery monitoring. As these trends continue to evolve, they will shape the future of drug testing, improving outcomes for individuals and communities worldwide.

Recent Developments in the Point-of-Care Testing (POCT) for Substance Abuse Market

Recent developments in the Point-of-Care Testing (POCT) for substance abuse market have been driven by technological advancements, the rise in substance abuse, and the need for more efficient testing solutions. These developments are transforming the landscape of drug testing in healthcare, workplaces, and law enforcement. Below are five key recent developments that are reshaping the market.

  • Introduction of Rapid, Multi-Drug Tests: Rapid, multi-drug tests have become a key development in the POCT market. These tests can detect various substances in a single sample, providing faster and more efficient results for healthcare providers, employers, and law enforcement agencies. By reducing the time and costs associated with running individual tests for each substance, multi-drug tests help streamline drug testing processes in a variety of settings. This development is essential for programs focused on monitoring patients with multiple substance use issues and for improving workplace safety.
  • Advances in Digital Integration for Real-Time Monitoring: Recent advances in digital technology have facilitated the integration of POCT devices with digital platforms for real-time monitoring and reporting. Healthcare providers and employers can now track drug test results instantly, ensuring quicker intervention and better management of substance abuse cases. This development is particularly beneficial in addiction treatment programs, where monitoring drug use over time is critical. It also enhances workplace drug testing programs by ensuring more accurate and timely decision-making.
  • Growth of Non-Invasive Testing Technologies: Non-invasive testing methods, such as saliva, sweat, and breath analysis, have made significant strides in the POCT market. These methods are less invasive and more convenient for patients, making them ideal for use in schools, workplaces, and healthcare settings. Non-invasive tests are also being adopted by law enforcement agencies for roadside drug testing, further expanding their use. As these technologies improve, they are expected to become more reliable and widely accepted, particularly in settings that require frequent or random testing.
  • Improved Accuracy and Sensitivity of Testing Devices: Recent advancements in POCT devices for substance abuse have focused on improving the accuracy and sensitivity of tests. This includes the development of more precise detection methods for low levels of substances in the body, such as fentanyl, which is becoming a significant concern in the opioid epidemic. By increasing the reliability of testing, these innovations help reduce false positives and negatives, ensuring that results are accurate and trustworthy. Improved accuracy is crucial for addiction treatment and workplace drug testing, as well as for monitoring law enforcement situations.
  • Regulatory Support for Expedited Approvals of Testing Devices: Regulatory bodies are providing more support for the expedited approval of POCT devices for substance abuse. This has led to the quicker availability of new and improved testing solutions in the market. For example, devices capable of detecting multiple drugs simultaneously have received faster regulatory approval, ensuring that healthcare providers, employers, and law enforcement agencies can access the tools they need to address the growing issue of substance abuse. This regulatory shift is driving innovation in the POCT market.

Recent developments in the POCT market for substance abuse, including multi-drug tests, digital integration, non-invasive testing, improved accuracy, and regulatory support, are revolutionizing the drug testing landscape. These advancements are improving the speed, accuracy, and accessibility of testing, which is essential for better substance abuse management across healthcare, workplace, and law enforcement settings. As these developments continue, they will play a significant role in combating the growing substance abuse epidemic.

Strategic Growth Opportunities in the Point-of-Care Testing (POCT) for Substance Abuse Market

The Point-of-Care Testing (POCT) for substance abuse market is expanding rapidly as more sectors look for efficient, accessible drug testing solutions. Key applications such as clinical diagnostics, workplace testing, and rehabilitation programs are creating growth opportunities for manufacturers. Here are five strategic growth opportunities within the POCT market for substance abuse.

  • Clinical Diagnostics in Addiction Treatment: Clinical diagnostics in addiction treatment is a major growth opportunity for POCT. Rapid testing for drugs allows healthcare providers to quickly assess patient conditions and monitor treatment progress. With more addiction treatment centers adopting POCT to track drug use and recovery, this sector is expected to continue growing. The ability to test patients frequently for a range of substances also helps in preventing relapse and ensuring patients receive appropriate care.
  • Workplace Testing for Drug Safety: Workplace drug testing is another key growth opportunity in the POCT market for substance abuse. Employers are increasingly adopting rapid drug testing solutions to ensure a safe and drug-free workplace. POCT devices that provide fast, reliable results are becoming essential for pre-employment screenings, random testing, and post-incident testing. The growing focus on workplace safety and productivity is driving the demand for these testing solutions.
  • At-Home Drug Testing Kits for Treatment Monitoring: At-home drug testing kits for individuals undergoing treatment or recovery programs represent an emerging growth opportunity. These kits offer convenience and privacy, enabling patients to monitor their substance use at home. As drug addiction continues to be a major public health issue, offering patients affordable and accessible home testing solutions will help them stay engaged in their recovery and reduce relapse rates.
  • Mobile Testing Units for Remote Areas: Mobile testing units for remote and underserved areas present a significant growth opportunity. These units allow for rapid testing in areas with limited access to healthcare facilities, improving drug abuse monitoring in rural areas. Mobile units are also helpful for law enforcement agencies and large employers who need on-site testing solutions. Expanding the reach of testing services into remote locations is critical for addressing the widespread nature of substance abuse.
  • Telemedicine Integration for Remote Monitoring: Telemedicine integration for remote monitoring of substance abuse is gaining traction as a growth opportunity. By combining POCT devices with telemedicine platforms, healthcare providers can remotely monitor patients and receive instant test results. This offers a more flexible and accessible approach to managing substance use disorders, particularly for patients in rural or underserved regions. This integration allows for real-time interventions and personalized treatment plans, improving patient outcomes.

Strategic growth opportunities in the POCT market for substance abuse lie in clinical diagnostics, workplace testing, at-home drug testing, mobile units, and telemedicine integration. These applications enhance the accessibility, efficiency, and affordability of drug testing, allowing for more effective substance abuse management across healthcare, workplaces, and remote areas. By focusing on these opportunities, manufacturers can help meet the growing demand for rapid, accurate drug testing solutions.

Point-of-Care Testing (POCT) for Substance Abuse Market Driver and Challenges

The Point-of-Care Testing (POCT) for substance abuse market is influenced by various drivers and challenges that impact its growth. Technological innovations, the rising prevalence of substance abuse, and regulatory support are driving the market, while economic, regulatory, and technical challenges continue to pose obstacles. Understanding these factors is crucial for companies looking to succeed in this evolving market.

The factors responsible for driving the point-of-care testing (POCT) for substance abuse market include:

1. Technological Advancements: Technological innovations in POCT devices are a primary driver of market growth. Advances in multiplex testing, non-invasive testing methods, and integration with digital health platforms have increased the efficiency and accuracy of drug testing. These developments make POCT solutions more accessible, cost-effective, and reliable, driving adoption across healthcare, workplaces, and law enforcement settings. As technology continues to evolve, it is expected to further enhance the capabilities of POCT devices, expanding their applications and improving outcomes.

2. Rising Substance Abuse: The increasing prevalence of substance abuse, particularly opioids, is a major driver of the POCT market. As addiction rates continue to rise, the demand for fast and accurate drug testing solutions grows. POCT enables healthcare providers and law enforcement agencies to respond more quickly to substance use and intervene early. The opioid epidemic, in particular, has highlighted the need for rapid testing to detect drug abuse and prevent overdose deaths, making POCT solutions essential for public health efforts.

3. Workplace Safety and Compliance: Workplace safety regulations are driving the demand for POCT solutions. Employers are increasingly adopting drug testing to ensure a safe and productive work environment. Rapid, accurate testing allows employers to meet compliance requirements and manage risks related to substance abuse in the workplace. As more companies prioritize drug-free environments, the demand for POCT devices in this sector is expected to grow, particularly in industries with safety-sensitive roles.

4. Regulatory Support: Governments and regulatory bodies are providing support for the development and approval of POCT devices for substance abuse. Faster regulatory approvals and more streamlined processes are helping companies bring new products to market more quickly. This regulatory environment encourages innovation and investment in POCT technology, making it easier for manufacturers to develop and introduce advanced solutions. Regulatory support also helps establish standards for testing accuracy and reliability, ensuring consistent quality across the market.

5. Patient-Centric Healthcare Approach: The shift towards a more patient-centric healthcare approach, where patients take an active role in managing their health, is driving demand for at-home drug testing solutions. Patients with substance use disorders benefit from the ability to monitor their drug use and stay engaged in their recovery process. POCT devices that enable self-testing are becoming increasingly popular, especially in addiction treatment programs that prioritize patient autonomy and continuous care.

Challenges in the point-of-care testing (POCT) for substance abuse market are:

1. Regulatory Hurdles: Regulatory challenges remain a significant barrier to the growth of the POCT market for substance abuse. Different countries have varying regulations and approval processes for POCT devices, which can delay the introduction of new products. Manufacturers must navigate complex regulatory requirements to ensure compliance, which can increase development costs and time to market. These hurdles can be particularly challenging for smaller companies with limited resources.

2. High Development Costs: The development and production of POCT devices for substance abuse can be costly, particularly for advanced testing technologies that require specialized materials and components. High development costs can result in higher prices for end users, limiting access to testing solutions in low-income regions. Manufacturers must find ways to reduce production costs without compromising the quality and accuracy of the tests to ensure affordability and wider adoption.

3. Accuracy and Reliability Concerns: While POCT devices have made significant advancements, there are still concerns regarding the accuracy and reliability of certain tests. False positives or false negatives can undermine the effectiveness of POCT, leading to misdiagnosis or mismanagement of substance abuse. Manufacturers must continue to improve the precision of their testing devices and ensure that they meet rigorous performance standards to gain widespread acceptance in healthcare, workplace, and law enforcement settings.

The major drivers of the POCT market for substance abuse include technological advancements, rising substance abuse, workplace safety concerns, regulatory support, and a patient-centric healthcare approach. However, challenges such as regulatory hurdles, high development costs, and accuracy concerns still need to be addressed. By overcoming these obstacles, the POCT market for substance abuse can continue to grow and provide essential tools for addressing the global substance abuse crisis.

List of Point-of-Care Testing (POCT) Companies for Substance Abuse Market

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies point-of-care testing (POCT) companies for substance abuse market cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the point-of-care testing (POCT) companies for substance abuse market are profiled in this report include-

  • Roche
  • Danaher
  • Abbott
  • Siemens
  • Beijing Hotgen Biotech
  • Hangzhou Biotest Biotech Co.
  • Assure Tech
  • Orient Gene
  • Thermo Fisher

Point-of-Care Testing (POCT) for Substance Abuse Market by Segment

The study includes a forecast for the global point-of-care testing (POCT) for substance abuse market by type, application, and region.

Point-of-Care Testing (POCT) for Substance Abuse Market by Type [Value from 2019 to 2031]:

  • Based on Colloidal Gold
  • Based on Fluorescence Immunochromatography

Point-of-Care Testing (POCT) for Substance Abuse Market by Application [Value from 2019 to 2031]:

  • Hospital
  • Diagnostic Center
  • Rehabilitation Centers
  • Workplace Testing Facilities
  • Home Testing Kits

Point-of-Care Testing (POCT) for Substance Abuse Market by Region [Value from 2019 to 2031]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

Country Wise Outlook for the Point-of-Care Testing (POCT) for Substance Abuse Market

The Point-of-Care Testing (POCT) for substance abuse market is growing rapidly due to the increasing need for fast, accessible, and accurate drug testing solutions. POCT allows for the immediate detection of substances like opioids, cocaine, marijuana, and alcohol in various settings such as healthcare facilities, workplaces, and law enforcement. With the rise of substance abuse, especially opioid-related issues, countries like the United States, China, Germany, India, and Japan are increasingly adopting these technologies. In these countries, POCT is becoming a crucial tool for addressing addiction, ensuring workplace safety, and monitoring patients' substance use, reflecting key advancements in testing technologies.

  • United States: In the United States, the POCT market for substance abuse has expanded significantly due to the growing opioid crisis and a rising need for rapid drug testing in healthcare and workplace environments. Recent developments include more advanced urine, saliva, and hair follicle tests for a broader range of substances. There has been a push towards integrating digital solutions with POCT devices to streamline reporting and monitoring. Furthermore, the FDA has approved new POCT devices capable of detecting multiple drugs simultaneously, improving efficiency and accessibility. These developments are aimed at enhancing patient care and helping with drug monitoring programs.
  • China: The Chinese POCT market for substance abuse is also expanding as part of a broader effort to combat drug-related issues. The country has witnessed a rise in POCT devices capable of detecting substances like methamphetamine, heroin, and opiates, which is especially relevant as the government works to control the abuse of illegal drugs. Local manufacturers are developing affordable and accessible testing solutions tailored to meet the needs of public health systems, police forces, and businesses. China is also increasing its focus on integrating POCT technology into routine healthcare, contributing to better monitoring of individuals undergoing rehabilitation for drug addiction.
  • Germany: Germany has seen notable advancements in the POCT market for substance abuse due to stricter regulations and a growing awareness of addiction issues. Germany's healthcare system is increasingly adopting POCT for detecting drugs in patients with addiction disorders and in workplace environments. Recently, the development of more accurate and sensitive testing devices for opioids and other common illicit drugs has been a key trend. There is also a push towards better integration with digital health platforms to improve the monitoring of treatment adherence and drug rehabilitation outcomes. These developments are driving the adoption of POCT technology across public health and law enforcement sectors.
  • India: In India, the POCT market for substance abuse is emerging due to the increasing need for rapid drug testing in various sectors, including healthcare, law enforcement, and the workplace. Recent developments include the introduction of affordable and portable drug testing kits that are especially beneficial in rural areas with limited access to traditional laboratory facilities. India's push to address rising substance abuse and addiction problems has led to government initiatives supporting the use of POCT devices in public health campaigns. These efforts are also coupled with the growth of telemedicine, facilitating remote testing and consultation, which enhances accessibility for patients in remote areas.
  • Japan: Japan is witnessing growth in the POCT market for substance abuse, driven by rising concerns about drug use among the younger population. Recent advancements include the development of highly accurate tests for a wide range of substances, including amphetamines, narcotics, and cannabis. Japan's regulatory framework supports the use of POCT in workplaces and law enforcement, with a focus on non-invasive testing methods like saliva and sweat testing. Additionally, innovations in mobile testing units and the integration of POCT with digital health platforms for real-time monitoring are further accelerating the adoption of substance abuse testing solutions in the country.

Features of the Global Point-of-Care Testing (POCT) for Substance Abuse Market

  • Market Size Estimates: Point-of-care testing (POCT) for substance abuse market size estimation in terms of value ($B).
  • Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.
  • Segmentation Analysis: Point-of-care testing (POCT) for substance abuse market size by type, application, and region in terms of value ($B).
  • Regional Analysis: Point-of-care testing (POCT) for substance abuse market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
  • Growth Opportunities: Analysis of growth opportunities in different types, applications, and regions for the point-of-care testing (POCT) for substance abuse market.
  • Strategic Analysis: This includes M&A, new product development, and competitive landscape of the point-of-care testing (POCT) for substance abuse market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the point-of-care testing (POCT) for substance abuse market by type (based on colloidal gold and based on fluorescence immunochromatography), application (hospital, diagnostic center, rehabilitation centers, workplace testing facilities, and home testing kits), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Market Overview

  • 2.1 Background and Classifications
  • 2.2 Supply Chain

3. Market Trends & Forecast Analysis

  • 3.1 Macroeconomic Trends and Forecasts
  • 3.2 Industry Drivers and Challenges
  • 3.3 PESTLE Analysis
  • 3.4 Patent Analysis
  • 3.5 Regulatory Environment

4. Global Point-of-Care Testing (POCT) for Substance Abuse Market by Type

  • 4.1 Overview
  • 4.2 Attractiveness Analysis by Type
  • 4.3 Based on Colloidal Gold: Trends and Forecast (2019-2031)
  • 4.4 Based on Fluorescence Immunochromatography: Trends and Forecast (2019-2031)

5. Global Point-of-Care Testing (POCT) for Substance Abuse Market by Application

  • 5.1 Overview
  • 5.2 Attractiveness Analysis by Application
  • 5.3 Hospital: Trends and Forecast (2019-2031)
  • 5.4 Diagnostic Center: Trends and Forecast (2019-2031)
  • 5.5 Rehabilitation Centers: Trends and Forecast (2019-2031)
  • 5.6 Workplace Testing Facilities: Trends and Forecast (2019-2031)
  • 5.7 Home Testing Kits: Trends and Forecast (2019-2031)

6. Regional Analysis

  • 6.1 Overview
  • 6.2 Global Point-of-Care Testing (POCT) for Substance Abuse Market by Region

7. North American Point-of-Care Testing (POCT) for Substance Abuse Market

  • 7.1 Overview
  • 7.2 North American Point-of-Care Testing (POCT) for Substance Abuse Market by Type
  • 7.3 North American Point-of-Care Testing (POCT) for Substance Abuse Market by Application
  • 7.4 United States Point-of-Care Testing (POCT) for Substance Abuse Market
  • 7.5 Mexican Point-of-Care Testing (POCT) for Substance Abuse Market
  • 7.6 Canadian Point-of-Care Testing (POCT) for Substance Abuse Market

8. European Point-of-Care Testing (POCT) for Substance Abuse Market

  • 8.1 Overview
  • 8.2 European Point-of-Care Testing (POCT) for Substance Abuse Market by Type
  • 8.3 European Point-of-Care Testing (POCT) for Substance Abuse Market by Application
  • 8.4 German Point-of-Care Testing (POCT) for Substance Abuse Market
  • 8.5 French Point-of-Care Testing (POCT) for Substance Abuse Market
  • 8.6 Spanish Point-of-Care Testing (POCT) for Substance Abuse Market
  • 8.7 Italian Point-of-Care Testing (POCT) for Substance Abuse Market
  • 8.8 United Kingdom Point-of-Care Testing (POCT) for Substance Abuse Market

9. APAC Point-of-Care Testing (POCT) for Substance Abuse Market

  • 9.1 Overview
  • 9.2 APAC Point-of-Care Testing (POCT) for Substance Abuse Market by Type
  • 9.3 APAC Point-of-Care Testing (POCT) for Substance Abuse Market by Application
  • 9.4 Japanese Point-of-Care Testing (POCT) for Substance Abuse Market
  • 9.5 Indian Point-of-Care Testing (POCT) for Substance Abuse Market
  • 9.6 Chinese Point-of-Care Testing (POCT) for Substance Abuse Market
  • 9.7 South Korean Point-of-Care Testing (POCT) for Substance Abuse Market
  • 9.8 Indonesian Point-of-Care Testing (POCT) for Substance Abuse Market

10. ROW Point-of-Care Testing (POCT) for Substance Abuse Market

  • 10.1 Overview
  • 10.2 ROW Point-of-Care Testing (POCT) for Substance Abuse Market by Type
  • 10.3 ROW Point-of-Care Testing (POCT) for Substance Abuse Market by Application
  • 10.4 Middle Eastern Point-of-Care Testing (POCT) for Substance Abuse Market
  • 10.5 South American Point-of-Care Testing (POCT) for Substance Abuse Market
  • 10.6 African Point-of-Care Testing (POCT) for Substance Abuse Market

11. Competitor Analysis

  • 11.1 Product Portfolio Analysis
  • 11.2 Operational Integration
  • 11.3 Porter's Five Forces Analysis
    • Competitive Rivalry
    • Bargaining Power of Buyers
    • Bargaining Power of Suppliers
    • Threat of Substitutes
    • Threat of New Entrants
  • 11.4 Market Share Analysis

12. Opportunities & Strategic Analysis

  • 12.1 Value Chain Analysis
  • 12.2 Growth Opportunity Analysis
    • 12.2.1 Growth Opportunities by Type
    • 12.2.2 Growth Opportunities by Application
  • 12.3 Emerging Trends in the Global Point-of-Care Testing (POCT) for Substance Abuse Market
  • 12.4 Strategic Analysis
    • 12.4.1 New Product Development
    • 12.4.2 Certification and Licensing
    • 12.4.3 Mergers, Acquisitions, Agreements, Collaborations, and Joint Ventures

13. Company Profiles of the Leading Players Across the Value Chain

  • 13.1 Competitive Analysis
  • 13.2 Roche
    • Company Overview
    • Point-of-Care Testing (POCT) for Substance Abuse Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.3 Danaher
    • Company Overview
    • Point-of-Care Testing (POCT) for Substance Abuse Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.4 Abbott
    • Company Overview
    • Point-of-Care Testing (POCT) for Substance Abuse Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.5 Siemens
    • Company Overview
    • Point-of-Care Testing (POCT) for Substance Abuse Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.6 Beijing Hotgen Biotech
    • Company Overview
    • Point-of-Care Testing (POCT) for Substance Abuse Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.7 Hangzhou Biotest Biotech Co.
    • Company Overview
    • Point-of-Care Testing (POCT) for Substance Abuse Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.8 Assure Tech
    • Company Overview
    • Point-of-Care Testing (POCT) for Substance Abuse Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.9 Orient Gene
    • Company Overview
    • Point-of-Care Testing (POCT) for Substance Abuse Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.10 Thermo Fisher
    • Company Overview
    • Point-of-Care Testing (POCT) for Substance Abuse Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing

14. Appendix

  • 14.1 List of Figures
  • 14.2 List of Tables
  • 14.3 Research Methodology
  • 14.4 Disclaimer
  • 14.5 Copyright
  • 14.6 Abbreviations and Technical Units
  • 14.7 About Us
  • 14.8 Contact Us

List of Figures

  • Figure 1.1: Trends and Forecast for the Global Point-of-Care Testing (POCT) for Substance Abuse Market
  • Figure 2.1: Usage of Point-of-Care Testing (POCT) for Substance Abuse Market
  • Figure 2.2: Classification of the Global Point-of-Care Testing (POCT) for Substance Abuse Market
  • Figure 2.3: Supply Chain of the Global Point-of-Care Testing (POCT) for Substance Abuse Market
  • Figure 3.1: Trends of the Global GDP Growth Rate
  • Figure 3.2: Trends of the Global Population Growth Rate
  • Figure 3.3: Trends of the Global Inflation Rate
  • Figure 3.4: Trends of the Global Unemployment Rate
  • Figure 3.5: Trends of the Regional GDP Growth Rate
  • Figure 3.6: Trends of the Regional Population Growth Rate
  • Figure 3.7: Trends of the Regional Inflation Rate
  • Figure 3.8: Trends of the Regional Unemployment Rate
  • Figure 3.9: Trends of Regional Per Capita Income
  • Figure 3.10: Forecast for the Global GDP Growth Rate
  • Figure 3.11: Forecast for the Global Population Growth Rate
  • Figure 3.12: Forecast for the Global Inflation Rate
  • Figure 3.13: Forecast for the Global Unemployment Rate
  • Figure 3.14: Forecast for the Regional GDP Growth Rate
  • Figure 3.15: Forecast for the Regional Population Growth Rate
  • Figure 3.16: Forecast for the Regional Inflation Rate
  • Figure 3.17: Forecast for the Regional Unemployment Rate
  • Figure 3.18: Forecast for Regional Per Capita Income
  • Figure 3.19: Driver and Challenges of the Point-of-Care Testing (POCT) for Substance Abuse Market
  • Figure 4.1: Global Point-of-Care Testing (POCT) for Substance Abuse Market by Type in 2019, 2024, and 2031
  • Figure 4.2: Trends of the Global Point-of-Care Testing (POCT) for Substance Abuse Market ($B) by Type
  • Figure 4.3: Forecast for the Global Point-of-Care Testing (POCT) for Substance Abuse Market ($B) by Type
  • Figure 4.4: Trends and Forecast for Based on Colloidal Gold in the Global Point-of-Care Testing (POCT) for Substance Abuse Market (2019-2031)
  • Figure 4.5: Trends and Forecast for Based on Fluorescence Immunochromatography in the Global Point-of-Care Testing (POCT) for Substance Abuse Market (2019-2031)
  • Figure 5.1: Global Point-of-Care Testing (POCT) for Substance Abuse Market by Application in 2019, 2024, and 2031
  • Figure 5.2: Trends of the Global Point-of-Care Testing (POCT) for Substance Abuse Market ($B) by Application
  • Figure 5.3: Forecast for the Global Point-of-Care Testing (POCT) for Substance Abuse Market ($B) by Application
  • Figure 5.4: Trends and Forecast for Hospital in the Global Point-of-Care Testing (POCT) for Substance Abuse Market (2019-2031)
  • Figure 5.5: Trends and Forecast for Diagnostic Center in the Global Point-of-Care Testing (POCT) for Substance Abuse Market (2019-2031)
  • Figure 5.6: Trends and Forecast for Rehabilitation Centers in the Global Point-of-Care Testing (POCT) for Substance Abuse Market (2019-2031)
  • Figure 5.7: Trends and Forecast for Workplace Testing Facilities in the Global Point-of-Care Testing (POCT) for Substance Abuse Market (2019-2031)
  • Figure 5.8: Trends and Forecast for Home Testing Kits in the Global Point-of-Care Testing (POCT) for Substance Abuse Market (2019-2031)
  • Figure 6.1: Trends of the Global Point-of-Care Testing (POCT) for Substance Abuse Market ($B) by Region (2019-2024)
  • Figure 6.2: Forecast for the Global Point-of-Care Testing (POCT) for Substance Abuse Market ($B) by Region (2025-2031)
  • Figure 7.1: Trends and Forecast for the North American Point-of-Care Testing (POCT) for Substance Abuse Market (2019-2031)
  • Figure 7.2: North American Point-of-Care Testing (POCT) for Substance Abuse Market by Type in 2019, 2024, and 2031
  • Figure 7.3: Trends of the North American Point-of-Care Testing (POCT) for Substance Abuse Market ($B) by Type (2019-2024)
  • Figure 7.4: Forecast for the North American Point-of-Care Testing (POCT) for Substance Abuse Market ($B) by Type (2025-2031)
  • Figure 7.5: North American Point-of-Care Testing (POCT) for Substance Abuse Market by Application in 2019, 2024, and 2031
  • Figure 7.6: Trends of the North American Point-of-Care Testing (POCT) for Substance Abuse Market ($B) by Application (2019-2024)
  • Figure 7.7: Forecast for the North American Point-of-Care Testing (POCT) for Substance Abuse Market ($B) by Application (2025-2031)
  • Figure 7.8: Trends and Forecast for the United States Point-of-Care Testing (POCT) for Substance Abuse Market ($B) (2019-2031)
  • Figure 7.9: Trends and Forecast for the Mexican Point-of-Care Testing (POCT) for Substance Abuse Market ($B) (2019-2031)
  • Figure 7.10: Trends and Forecast for the Canadian Point-of-Care Testing (POCT) for Substance Abuse Market ($B) (2019-2031)
  • Figure 8.1: Trends and Forecast for the European Point-of-Care Testing (POCT) for Substance Abuse Market (2019-2031)
  • Figure 8.2: European Point-of-Care Testing (POCT) for Substance Abuse Market by Type in 2019, 2024, and 2031
  • Figure 8.3: Trends of the European Point-of-Care Testing (POCT) for Substance Abuse Market ($B) by Type (2019-2024)
  • Figure 8.4: Forecast for the European Point-of-Care Testing (POCT) for Substance Abuse Market ($B) by Type (2025-2031)
  • Figure 8.5: European Point-of-Care Testing (POCT) for Substance Abuse Market by Application in 2019, 2024, and 2031
  • Figure 8.6: Trends of the European Point-of-Care Testing (POCT) for Substance Abuse Market ($B) by Application (2019-2024)
  • Figure 8.7: Forecast for the European Point-of-Care Testing (POCT) for Substance Abuse Market ($B) by Application (2025-2031)
  • Figure 8.8: Trends and Forecast for the German Point-of-Care Testing (POCT) for Substance Abuse Market ($B) (2019-2031)
  • Figure 8.9: Trends and Forecast for the French Point-of-Care Testing (POCT) for Substance Abuse Market ($B) (2019-2031)
  • Figure 8.10: Trends and Forecast for the Spanish Point-of-Care Testing (POCT) for Substance Abuse Market ($B) (2019-2031)
  • Figure 8.11: Trends and Forecast for the Italian Point-of-Care Testing (POCT) for Substance Abuse Market ($B) (2019-2031)
  • Figure 8.12: Trends and Forecast for the United Kingdom Point-of-Care Testing (POCT) for Substance Abuse Market ($B) (2019-2031)
  • Figure 9.1: Trends and Forecast for the APAC Point-of-Care Testing (POCT) for Substance Abuse Market (2019-2031)
  • Figure 9.2: APAC Point-of-Care Testing (POCT) for Substance Abuse Market by Type in 2019, 2024, and 2031
  • Figure 9.3: Trends of the APAC Point-of-Care Testing (POCT) for Substance Abuse Market ($B) by Type (2019-2024)
  • Figure 9.4: Forecast for the APAC Point-of-Care Testing (POCT) for Substance Abuse Market ($B) by Type (2025-2031)
  • Figure 9.5: APAC Point-of-Care Testing (POCT) for Substance Abuse Market by Application in 2019, 2024, and 2031
  • Figure 9.6: Trends of the APAC Point-of-Care Testing (POCT) for Substance Abuse Market ($B) by Application (2019-2024)
  • Figure 9.7: Forecast for the APAC Point-of-Care Testing (POCT) for Substance Abuse Market ($B) by Application (2025-2031)
  • Figure 9.8: Trends and Forecast for the Japanese Point-of-Care Testing (POCT) for Substance Abuse Market ($B) (2019-2031)
  • Figure 9.9: Trends and Forecast for the Indian Point-of-Care Testing (POCT) for Substance Abuse Market ($B) (2019-2031)
  • Figure 9.10: Trends and Forecast for the Chinese Point-of-Care Testing (POCT) for Substance Abuse Market ($B) (2019-2031)
  • Figure 9.11: Trends and Forecast for the South Korean Point-of-Care Testing (POCT) for Substance Abuse Market ($B) (2019-2031)
  • Figure 9.12: Trends and Forecast for the Indonesian Point-of-Care Testing (POCT) for Substance Abuse Market ($B) (2019-2031)
  • Figure 10.1: Trends and Forecast for the ROW Point-of-Care Testing (POCT) for Substance Abuse Market (2019-2031)
  • Figure 10.2: ROW Point-of-Care Testing (POCT) for Substance Abuse Market by Type in 2019, 2024, and 2031
  • Figure 10.3: Trends of the ROW Point-of-Care Testing (POCT) for Substance Abuse Market ($B) by Type (2019-2024)
  • Figure 10.4: Forecast for the ROW Point-of-Care Testing (POCT) for Substance Abuse Market ($B) by Type (2025-2031)
  • Figure 10.5: ROW Point-of-Care Testing (POCT) for Substance Abuse Market by Application in 2019, 2024, and 2031
  • Figure 10.6: Trends of the ROW Point-of-Care Testing (POCT) for Substance Abuse Market ($B) by Application (2019-2024)
  • Figure 10.7: Forecast for the ROW Point-of-Care Testing (POCT) for Substance Abuse Market ($B) by Application (2025-2031)
  • Figure 10.8: Trends and Forecast for the Middle Eastern Point-of-Care Testing (POCT) for Substance Abuse Market ($B) (2019-2031)
  • Figure 10.9: Trends and Forecast for the South American Point-of-Care Testing (POCT) for Substance Abuse Market ($B) (2019-2031)
  • Figure 10.10: Trends and Forecast for the African Point-of-Care Testing (POCT) for Substance Abuse Market ($B) (2019-2031)
  • Figure 11.1: Porter's Five Forces Analysis of the Global Point-of-Care Testing (POCT) for Substance Abuse Market
  • Figure 11.2: Market Share (%) of Top Players in the Global Point-of-Care Testing (POCT) for Substance Abuse Market (2024)
  • Figure 12.1: Growth Opportunities for the Global Point-of-Care Testing (POCT) for Substance Abuse Market by Type
  • Figure 12.2: Growth Opportunities for the Global Point-of-Care Testing (POCT) for Substance Abuse Market by Application
  • Figure 12.3: Growth Opportunities for the Global Point-of-Care Testing (POCT) for Substance Abuse Market by Region
  • Figure 12.4: Emerging Trends in the Global Point-of-Care Testing (POCT) for Substance Abuse Market

List of Tables

  • Table 1.1: Growth Rate (%, 2023-2024) and CAGR (%, 2025-2031) of the Point-of-Care Testing (POCT) for Substance Abuse Market by Type and Application
  • Table 1.2: Attractiveness Analysis for the Point-of-Care Testing (POCT) for Substance Abuse Market by Region
  • Table 1.3: Global Point-of-Care Testing (POCT) for Substance Abuse Market Parameters and Attributes
  • Table 3.1: Trends of the Global Point-of-Care Testing (POCT) for Substance Abuse Market (2019-2024)
  • Table 3.2: Forecast for the Global Point-of-Care Testing (POCT) for Substance Abuse Market (2025-2031)
  • Table 4.1: Attractiveness Analysis for the Global Point-of-Care Testing (POCT) for Substance Abuse Market by Type
  • Table 4.2: Market Size and CAGR of Various Type in the Global Point-of-Care Testing (POCT) for Substance Abuse Market (2019-2024)
  • Table 4.3: Market Size and CAGR of Various Type in the Global Point-of-Care Testing (POCT) for Substance Abuse Market (2025-2031)
  • Table 4.4: Trends of Based on Colloidal Gold in the Global Point-of-Care Testing (POCT) for Substance Abuse Market (2019-2024)
  • Table 4.5: Forecast for Based on Colloidal Gold in the Global Point-of-Care Testing (POCT) for Substance Abuse Market (2025-2031)
  • Table 4.6: Trends of Based on Fluorescence Immunochromatography in the Global Point-of-Care Testing (POCT) for Substance Abuse Market (2019-2024)
  • Table 4.7: Forecast for Based on Fluorescence Immunochromatography in the Global Point-of-Care Testing (POCT) for Substance Abuse Market (2025-2031)
  • Table 5.1: Attractiveness Analysis for the Global Point-of-Care Testing (POCT) for Substance Abuse Market by Application
  • Table 5.2: Market Size and CAGR of Various Application in the Global Point-of-Care Testing (POCT) for Substance Abuse Market (2019-2024)
  • Table 5.3: Market Size and CAGR of Various Application in the Global Point-of-Care Testing (POCT) for Substance Abuse Market (2025-2031)
  • Table 5.4: Trends of Hospital in the Global Point-of-Care Testing (POCT) for Substance Abuse Market (2019-2024)
  • Table 5.5: Forecast for Hospital in the Global Point-of-Care Testing (POCT) for Substance Abuse Market (2025-2031)
  • Table 5.6: Trends of Diagnostic Center in the Global Point-of-Care Testing (POCT) for Substance Abuse Market (2019-2024)
  • Table 5.7: Forecast for Diagnostic Center in the Global Point-of-Care Testing (POCT) for Substance Abuse Market (2025-2031)
  • Table 5.8: Trends of Rehabilitation Centers in the Global Point-of-Care Testing (POCT) for Substance Abuse Market (2019-2024)
  • Table 5.9: Forecast for Rehabilitation Centers in the Global Point-of-Care Testing (POCT) for Substance Abuse Market (2025-2031)
  • Table 5.10: Trends of Workplace Testing Facilities in the Global Point-of-Care Testing (POCT) for Substance Abuse Market (2019-2024)
  • Table 5.11: Forecast for Workplace Testing Facilities in the Global Point-of-Care Testing (POCT) for Substance Abuse Market (2025-2031)
  • Table 5.12: Trends of Home Testing Kits in the Global Point-of-Care Testing (POCT) for Substance Abuse Market (2019-2024)
  • Table 5.13: Forecast for Home Testing Kits in the Global Point-of-Care Testing (POCT) for Substance Abuse Market (2025-2031)
  • Table 6.1: Market Size and CAGR of Various Regions in the Global Point-of-Care Testing (POCT) for Substance Abuse Market (2019-2024)
  • Table 6.2: Market Size and CAGR of Various Regions in the Global Point-of-Care Testing (POCT) for Substance Abuse Market (2025-2031)
  • Table 7.1: Trends of the North American Point-of-Care Testing (POCT) for Substance Abuse Market (2019-2024)
  • Table 7.2: Forecast for the North American Point-of-Care Testing (POCT) for Substance Abuse Market (2025-2031)
  • Table 7.3: Market Size and CAGR of Various Type in the North American Point-of-Care Testing (POCT) for Substance Abuse Market (2019-2024)
  • Table 7.4: Market Size and CAGR of Various Type in the North American Point-of-Care Testing (POCT) for Substance Abuse Market (2025-2031)
  • Table 7.5: Market Size and CAGR of Various Application in the North American Point-of-Care Testing (POCT) for Substance Abuse Market (2019-2024)
  • Table 7.6: Market Size and CAGR of Various Application in the North American Point-of-Care Testing (POCT) for Substance Abuse Market (2025-2031)
  • Table 7.7: Trends and Forecast for the United States Point-of-Care Testing (POCT) for Substance Abuse Market (2019-2031)
  • Table 7.8: Trends and Forecast for the Mexican Point-of-Care Testing (POCT) for Substance Abuse Market (2019-2031)
  • Table 7.9: Trends and Forecast for the Canadian Point-of-Care Testing (POCT) for Substance Abuse Market (2019-2031)
  • Table 8.1: Trends of the European Point-of-Care Testing (POCT) for Substance Abuse Market (2019-2024)
  • Table 8.2: Forecast for the European Point-of-Care Testing (POCT) for Substance Abuse Market (2025-2031)
  • Table 8.3: Market Size and CAGR of Various Type in the European Point-of-Care Testing (POCT) for Substance Abuse Market (2019-2024)
  • Table 8.4: Market Size and CAGR of Various Type in the European Point-of-Care Testing (POCT) for Substance Abuse Market (2025-2031)
  • Table 8.5: Market Size and CAGR of Various Application in the European Point-of-Care Testing (POCT) for Substance Abuse Market (2019-2024)
  • Table 8.6: Market Size and CAGR of Various Application in the European Point-of-Care Testing (POCT) for Substance Abuse Market (2025-2031)
  • Table 8.7: Trends and Forecast for the German Point-of-Care Testing (POCT) for Substance Abuse Market (2019-2031)
  • Table 8.8: Trends and Forecast for the French Point-of-Care Testing (POCT) for Substance Abuse Market (2019-2031)
  • Table 8.9: Trends and Forecast for the Spanish Point-of-Care Testing (POCT) for Substance Abuse Market (2019-2031)
  • Table 8.10: Trends and Forecast for the Italian Point-of-Care Testing (POCT) for Substance Abuse Market (2019-2031)
  • Table 8.11: Trends and Forecast for the United Kingdom Point-of-Care Testing (POCT) for Substance Abuse Market (2019-2031)
  • Table 9.1: Trends of the APAC Point-of-Care Testing (POCT) for Substance Abuse Market (2019-2024)
  • Table 9.2: Forecast for the APAC Point-of-Care Testing (POCT) for Substance Abuse Market (2025-2031)
  • Table 9.3: Market Size and CAGR of Various Type in the APAC Point-of-Care Testing (POCT) for Substance Abuse Market (2019-2024)
  • Table 9.4: Market Size and CAGR of Various Type in the APAC Point-of-Care Testing (POCT) for Substance Abuse Market (2025-2031)
  • Table 9.5: Market Size and CAGR of Various Application in the APAC Point-of-Care Testing (POCT) for Substance Abuse Market (2019-2024)
  • Table 9.6: Market Size and CAGR of Various Application in the APAC Point-of-Care Testing (POCT) for Substance Abuse Market (2025-2031)
  • Table 9.7: Trends and Forecast for the Japanese Point-of-Care Testing (POCT) for Substance Abuse Market (2019-2031)
  • Table 9.8: Trends and Forecast for the Indian Point-of-Care Testing (POCT) for Substance Abuse Market (2019-2031)
  • Table 9.9: Trends and Forecast for the Chinese Point-of-Care Testing (POCT) for Substance Abuse Market (2019-2031)
  • Table 9.10: Trends and Forecast for the South Korean Point-of-Care Testing (POCT) for Substance Abuse Market (2019-2031)
  • Table 9.11: Trends and Forecast for the Indonesian Point-of-Care Testing (POCT) for Substance Abuse Market (2019-2031)
  • Table 10.1: Trends of the ROW Point-of-Care Testing (POCT) for Substance Abuse Market (2019-2024)
  • Table 10.2: Forecast for the ROW Point-of-Care Testing (POCT) for Substance Abuse Market (2025-2031)
  • Table 10.3: Market Size and CAGR of Various Type in the ROW Point-of-Care Testing (POCT) for Substance Abuse Market (2019-2024)
  • Table 10.4: Market Size and CAGR of Various Type in the ROW Point-of-Care Testing (POCT) for Substance Abuse Market (2025-2031)
  • Table 10.5: Market Size and CAGR of Various Application in the ROW Point-of-Care Testing (POCT) for Substance Abuse Market (2019-2024)
  • Table 10.6: Market Size and CAGR of Various Application in the ROW Point-of-Care Testing (POCT) for Substance Abuse Market (2025-2031)
  • Table 10.7: Trends and Forecast for the Middle Eastern Point-of-Care Testing (POCT) for Substance Abuse Market (2019-2031)
  • Table 10.8: Trends and Forecast for the South American Point-of-Care Testing (POCT) for Substance Abuse Market (2019-2031)
  • Table 10.9: Trends and Forecast for the African Point-of-Care Testing (POCT) for Substance Abuse Market (2019-2031)
  • Table 11.1: Product Mapping of Point-of-Care Testing (POCT) for Substance Abuse Suppliers Based on Segments
  • Table 11.2: Operational Integration of Point-of-Care Testing (POCT) for Substance Abuse Manufacturers
  • Table 11.3: Rankings of Suppliers Based on Point-of-Care Testing (POCT) for Substance Abuse Revenue
  • Table 12.1: New Product Launches by Major Point-of-Care Testing (POCT) for Substance Abuse Producers (2019-2024)
  • Table 12.2: Certification Acquired by Major Competitor in the Global Point-of-Care Testing (POCT) for Substance Abuse Market